CO4970788A1 - ORAL FORMULATIONS FOR HYDROPHILIC DRUGS - Google Patents

ORAL FORMULATIONS FOR HYDROPHILIC DRUGS

Info

Publication number
CO4970788A1
CO4970788A1 CO99011498A CO99011498A CO4970788A1 CO 4970788 A1 CO4970788 A1 CO 4970788A1 CO 99011498 A CO99011498 A CO 99011498A CO 99011498 A CO99011498 A CO 99011498A CO 4970788 A1 CO4970788 A1 CO 4970788A1
Authority
CO
Colombia
Prior art keywords
oral formulations
hydrophilic drugs
concentrate
hydrophilic
volume
Prior art date
Application number
CO99011498A
Other languages
Spanish (es)
Inventor
Ying Fu Lu Mou
John F Bauer
Walteer Dziki
Victor E Taylor
Wang Zheng
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO4970788A1 publication Critical patent/CO4970788A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un concentrado farmacéutico para administración oral quecontiene una droga hidrofílica solubilizada en una fase lipofílica que consiste de un ácido graso y agua. 2El proceso de la Reivindicación 21, en donde el concentrado contiene además un alcohol C1 -C5 que varía entre 0% y 60% en volumen del concentrado.A pharmaceutical concentrate for oral administration that contains a hydrophilic drug solubilized in a lipophilic phase consisting of a fatty acid and water. 2The process of Claim 21, wherein the concentrate further contains a C1-C5 alcohol ranging from 0% to 60% by volume of the concentrate.

CO99011498A 1998-02-26 1999-02-24 ORAL FORMULATIONS FOR HYDROPHILIC DRUGS CO4970788A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3120498A 1998-02-26 1998-02-26

Publications (1)

Publication Number Publication Date
CO4970788A1 true CO4970788A1 (en) 2000-11-07

Family

ID=21858162

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99011498A CO4970788A1 (en) 1998-02-26 1999-02-24 ORAL FORMULATIONS FOR HYDROPHILIC DRUGS

Country Status (5)

Country Link
AR (1) AR015531A1 (en)
AU (1) AU2870899A (en)
CO (1) CO4970788A1 (en)
WO (1) WO1999043299A2 (en)
ZA (1) ZA991539B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2153819B1 (en) 2000-07-14 2012-09-05 Allergan, Inc. Use of a solubility enhancing component in an aqueous composition comprising brimonidine tartrate
CN101897704B (en) 2000-07-14 2014-10-29 阿勒根公司 Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
ES2385240B1 (en) 2010-07-26 2013-09-23 Gp-Pharm, S.A. CAPSULES OF ACTIVE PHARMACEUTICAL PRINCIPLES AND POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF PROSTATE DISEASES.
CN116270492A (en) * 2023-03-30 2023-06-23 北京博恩特药业有限公司 Leuprolide acetate sustained-release microsphere for injection and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510046A (en) * 1991-08-26 1994-11-10 アボツト・ラボラトリーズ Compositions and methods for sublingual or buccal administration of therapeutic agents
JPH11292787A (en) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd Transucosal preparation containing physiologically active peptide
US5853740A (en) * 1996-08-07 1998-12-29 Abbott Laboratories Delivery system for pharmaceutical agents encapsulated with oils

Also Published As

Publication number Publication date
ZA991539B (en) 1999-08-25
AR015531A1 (en) 2001-05-02
AU2870899A (en) 1999-09-15
WO1999043299A2 (en) 1999-09-02
WO1999043299A3 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
AR017512A1 (en) TABLETS OF QUICKLY DISPOSABLE METILCELLULOSE FOR ORAL ROUTE ADMINISTRATION AND PROCEDURE TO PREPARE THEM
ES2156028T3 (en) Compositions containing tetrahydrolipstatin
AR046773A1 (en) PHARMACEUTICAL FORMULATIONS OF BISPHOSPHONATES
AR028299A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
BRPI0406996A (en) Sugar-free oral solid transmucosal dosage forms and their use
CO4750822A1 (en) TADA PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION IN THE GASTROINTESTINAL TRACT AND PROCESSES TO PREPARE THE SAME
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
BR9909266A (en) Effervescent formulations
CR7654A (en) A COMBINATION OF AZELATINE AND STEROIDS
FR2930140B1 (en) DEVICE FOR STORING, EXTENDED PREPARATION AND ADMINISTRATION OF A LOW ASSAY OF ACTIVE INGREDIENT
AR029159A1 (en) PHARMACEUTICAL PREPARATION, PACKAGE CONTAINING AND USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT IN HORMONAL REPLACEMENT THERAPY
CO5170471A1 (en) MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE
AR073793A1 (en) PHARMACEUTICAL FORMULATION LIQUID CONTAINING PARACETAMOL. EXCIPIENT LIQUID
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
ECSP044986A (en) PHARMACEUTICAL COMPOSITION INCLUDING LUMIRACOXIB
AR025790A1 (en) COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CIRCULATORY DISORDERS, WHICH INCLUDES DERIVATIVES OF L-CARNITINE AND GINKGO BILOBA EXTRACTS
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
CO4970788A1 (en) ORAL FORMULATIONS FOR HYDROPHILIC DRUGS
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
AR087240A2 (en) PHARMACEUTICAL COMPOSITIONS THAT HAVE EPINASTINE AND PSEUDOEFEDRINE
AR051742A1 (en) LERCANIDIPINE CAPSULES
CO4970832A1 (en) NEW FORMULATIONS AND PROCESSES FOR ITS MANUFACTURE
AR040515A1 (en) TOPICA PHARMACEUTICAL FORMULA STABILIZED WITH KETOPROPHENE CONTENT
RU2003105601A (en) DRUG FOR THE TREATMENT OF SEXUAL DISORDERS